Oklahoma City, OK, United States of America

Nathaniel Weygant

USPTO Granted Patents = 2 


Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Oklahoma City, OK (US) (2017)
  • Mustang, OK (US) (2023)

Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nathaniel Weygant: Innovator in Antibody Research

Introduction

Nathaniel Weygant is a prominent inventor based in Oklahoma City, OK. He has made significant contributions to the field of antibody research, particularly in the development of innovative methods and applications related to DCLK1 protein.

Latest Patents

Weygant holds 2 patents that focus on anti-doublecortin-like kinase 1 antibodies and their methods of use. His first patent details antibodies and antigen-binding fragments that specifically bind to the human DCLK1 protein. This patent also covers hybridomas or other cell lines that express such antibodies, as well as nucleic acids, vectors, and host cells that comprise nucleic acids encoding these antibodies. Notably, the antibodies specifically target an epitope within isoform 2 or 4 of the DCLK1 protein. His second patent involves monoclonal antibodies against DCLK1 and the methods of producing and utilizing these antibodies, including conjugates that contain them.

Career Highlights

Weygant is affiliated with the University of Oklahoma, where he continues to advance his research in antibody development. His work has the potential to impact various therapeutic applications, particularly in the realm of cancer research.

Collaborations

He collaborates with notable colleagues, including Courtney W. Houchen and Randal May, who contribute to his research endeavors and enhance the scope of his work.

Conclusion

Nathaniel Weygant's innovative research in antibody development showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic strategies in the treatment of diseases associated with DCLK1 protein.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…